<strike id="amuic"></strike>
  • <abbr id="amuic"><option id="amuic"></option></abbr>
    <strike id="amuic"></strike>
  • <cite id="amuic"><source id="amuic"></source></cite>
    <cite id="amuic"><source id="amuic"></source></cite>
  • <ul id="amuic"><table id="amuic"></table></ul>
    最近搜索:細胞培養 微生物學 分子生物 生物化學
    首頁>>免疫學>>一抗>>骨保護蛋白配體/破骨細胞分化因子抗體
    骨保護蛋白配體/破骨細胞分化因子抗體
    • 產品貨號:
      BN40620R
    • 中文名稱:
      骨保護蛋白配體/破骨細胞分化因子抗體
    • 英文名稱:
      Rabbit anti-RANKL/CD254 Polyclonal antibody
    • 品牌:
      Biorigin
    • 貨號

      產品規格

      售價

      備注

    • BN40620R-100ul

      100ul

      ¥2360.00

      交叉反應:Rat,Mouse,Human(predicted:Zebrafish,Rabbit,Horse,Cow,Pig,Dog) 推薦應用:WB,Flow-Cyt

    • BN40620R-200ul

      200ul

      ¥3490.00

      交叉反應:Rat,Mouse,Human(predicted:Zebrafish,Rabbit,Horse,Cow,Pig,Dog) 推薦應用:WB,Flow-Cyt

    產品描述

    英文名稱RANKL/CD254
    中文名稱骨保護蛋白配體/破骨細胞分化因子抗體
    別    名OPGL; CD254; hRANKL2; ODF; OPGL; Osteoclast differentiation factor; Osteoprotegerin ligand; RANKL; Receptor activator of nuclear factor kappa B ligand; sOdf; SOFA; TNF related activation induced cytokine; TNFSF 11; TNFSF11; TRANCE; Tumor necrosis factor ligand superfamily member 11; Osteoprotegerin Ligand; TNF11_HUMAN.  



    研究領域腫瘤  細胞生物  免疫學  發育生物學  
    抗體來源Rabbit
    克隆類型Polyclonal
    交叉反應Human, Mouse, Rat,  (predicted: Dog, Pig, Cow, Horse, Rabbit, )
    產品應用WB=1:500-2000 Flow-Cyt=1ug/Test 
    not yet tested in other applications.
    optimal dilutions/concentrations should be determined by the end user.
    分 子 量35kDa
    細胞定位細胞漿 細胞膜 分泌型蛋白 
    性    狀Liquid
    濃    度1mg/ml
    免 疫 原KLH conjugated synthetic peptide derived from human RANKL/CD254:41-140/317 
    亞    型IgG
    純化方法affinity purified by Protein A
    儲 存 液0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
    保存條件Shipped at 4℃. Store at -20 °C for one year. Avoid repeated freeze/thaw cycles.
    PubMedPubMed
    產品介紹This gene encodes a member of the tumor necrosis factor (TNF) cytokine family which is a ligand for osteoprotegerin and functions as a key factor for osteoclast differentiation and activation. This protein was shown to be a dentritic cell survival factor and is involved in the regulation of T cell-dependent immune response. T cell activation was reported to induce expression of this gene and lead to an increase of osteoclastogenesis and bone loss. This protein was shown to activate antiapoptotic kinase AKT/PKB through a signaling complex involving SRC kinase and tumor necrosis factor receptor-associated factor (TRAF) 6, which indicated this protein may have a role in the regulation of cell apoptosis. Targeted disruption of the related gene in mice led to severe osteopetrosis and a lack of osteoclasts. The deficient mice exhibited defects in early differentiation of T and B lymphocytes, and failed to form lobulo-alveolar mammary structures during pregnancy. Two alternatively spliced transcript variants have been found. [provided by RefSeq, Jul 2008].

    Function:
    Cytokine that binds to TNFRSF11B/OPG and to TNFRSF11A/RANK. Osteoclast differentiation and activation factor. Augments the ability of dendritic cells to stimulate naive T-cell proliferation. May be an important regulator of interactions between T-cells and dendritic cells and may play a role in the regulation of the T-cell-dependent immune response. May also play an important role in enhanced bone-resorption in humoral hypercalcemia of malignancy.

    Subcellular Location:
    Cytoplasm; Secreted and Cell membrane.

    Tissue Specificity:
    Highest in the peripheral lymph nodes, weak in spleen, peripheral blood Leukocytes, bone marrow, heart, placenta, skeletal muscle, stomach and thyroid.

    Post-translational modifications:
    The soluble form of isoform 1 derives from the membrane form by proteolytic processing. The cleavage may be catalyzed by ADAM17.

    DISEASE:
    Defects in TNFSF11 are the cause of osteopetrosis autosomal recessive type 2 (OPTB2) [MIM:259710]; also known as osteoclast-poor osteopetrosis. Osteopetrosis is a rare genetic disease characterized by abnormally dense bone, due to defective resorption of immature bone. The disorder occurs in two forms: a severe autosomal recessive form occurring in utero, infancy, or childhood, and a benign autosomal dominant form occurring in adolescence or adulthood. Autosomal recessive osteopetrosis is usually associated with normal or elevated amount of non-functional osteoclasts. OPTB2 is characterized by paucity of osteoclasts, suggesting a molecular defect in osteoclast development.

    Similarity:
    Belongs to the tumor necrosis factor family.

    SWISS:
    O14788

    Gene ID:
    8600

    Database links:

    Entrez Gene: 8600 Human

    Entrez Gene: 21943 Mouse

    Omim: 602642 Human

    SwissProt: O14788 Human

    SwissProt: O35235 Mouse

    Unigene: 333791 Human

    Unigene: 249221 Mouse



    Important Note:
    This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.

    OPGL骨保護蛋白配體又稱骨保護素配體(破骨細胞發育刺激因子)。屬腫瘤壞死因子TNF-a家族。
    OPGL促進破骨細胞的分化和活性,而OPG抑制這些過程。骨髓瘤細胞影響骨髓中這兩種蛋白的生理平衡,是發生溶骨性病變的根本所在。
























    image.png

    image.png

    image.png